Back to Search
Start Over
Mesenchymal Stem Cells in Clinical Trials for Immune Disorders.
- Source :
-
Global Medical Genetics . Sep2024, Vol. 11 Issue 3, p196-199. 4p. - Publication Year :
- 2024
-
Abstract
- A recent article in Global Medical Genetics discusses the use of mesenchymal stem cells (MSCs) in clinical trials for immune disorders. MSCs have unique properties, including regeneration and immunomodulation, which make them a promising therapeutic approach. The article highlights a phase I trial that used human umbilical cord-derived MSCs (UC-MSCs) to treat refractory immune thrombocytopenia (ITP), a hemorrhagic disease resulting from an immune imbalance. The trial showed that UC-MSCs increased platelet counts and improved bleeding symptoms in patients with refractory ITP. MSCs have the potential to treat various immune-related conditions, and further research is needed to understand their distribution and metabolism in organ tissues. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 26999404
- Volume :
- 11
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Global Medical Genetics
- Publication Type :
- Academic Journal
- Accession number :
- 178138920
- Full Text :
- https://doi.org/10.1055/s-0044-1788044